---
title: Research
---

# Research

<div class="card" style="max-width:980px; margin:18px auto; padding:16px; border-radius:14px; border:1px solid rgba(0,0,0,.08); background: rgba(0,0,0,.01);">

  <p class="small" style="margin:0 0 14px; line-height:1.65;">
    Our lab develops biomarker-driven strategies to enable <strong>early detection, risk stratification, and precision prevention</strong>.
    We combine mechanistic insight with clinically grounded assay development.
  </p>

  <hr style="margin:18px 0; border:none; border-top:1px solid rgba(0,0,0,.12);" />

  <h2 style="margin:0 0 8px;">1) Precision prevention and early detection</h2>
  <p class="small" style="margin:0 0 10px; line-height:1.65;">
    We aim to identify measurable biological signals that precede clinically evident cancer and enable non-invasive detection and surveillance.
  </p>
  <p class="small" style="margin:0; line-height:1.65;">
    <strong>Approach:</strong> curated cohorts, PRoBE-style principles when feasible, and clinically practical assay designs.
  </p>

  <hr style="margin:18px 0; border:none; border-top:1px solid rgba(0,0,0,.12);" />

  <h2 style="margin:0 0 8px;">2) Biomarker panels and assay development</h2>
  <p class="small" style="margin:0 0 10px; line-height:1.65;">
    We focus on translation: building assays that are robust, scalable, and compatible with real clinical workflows.
  </p>
  <p class="small" style="margin:0 0 8px; line-height:1.65;"><strong>Examples of translation priorities</strong></p>
  <ul class="small" style="margin:0 0 0 18px; line-height:1.65;">
    <li>multiplex protein panels (urine-based)</li>
    <li>reproducible QC frameworks and analytical validation thinking</li>
    <li>bridging discovery platforms → targeted assays</li>
  </ul>

  <hr style="margin:18px 0; border:none; border-top:1px solid rgba(0,0,0,.12);" />

  <h2 style="margin:0 0 8px;">3) Spatial and multi-omics biology</h2>
  <p class="small" style="margin:0 0 10px; line-height:1.65;">
    We connect tissue-level biology to urine/tissue biomarkers and outcomes.
  </p>
  <p class="small" style="margin:0 0 8px; line-height:1.65;"><strong>Methods (examples)</strong></p>
  <ul class="small" style="margin:0 0 0 18px; line-height:1.65;">
    <li>spatial transcriptomics / spatial proteomics</li>
    <li>bulk profiling + targeted validation</li>
    <li>integrative analysis across datasets and models</li>
  </ul>

  <hr style="margin:18px 0; border:none; border-top:1px solid rgba(0,0,0,.12);" />

  <h2 style="margin:0 0 8px;">4) Experimental models to support temporal biology</h2>
  <p class="small" style="margin:0; line-height:1.65;">
    We leverage models to understand how early tumor-associated states evolve over time and how they shape measurable biomarker signals.
  </p>

  <hr style="margin:18px 0; border:none; border-top:1px solid rgba(0,0,0,.12);" />

  <p class="small" style="margin:0; line-height:1.65;">
    If you’d like to collaborate, please reach out via <strong><a href="/contact">Contact</a></strong>.
  </p>

</div>
